BioAge Labs Upsized $115M Public Offering
Clinical-stage biopharmaceutical company BioAge Labs, Inc. (NASDAQ: BIOA) on Tuesday announced the pricing of its upsized public offering,…
Clinical-stage biopharmaceutical company BioAge Labs, Inc. (NASDAQ: BIOA) on Tuesday announced the pricing of its upsized public offering,…